首页> 外文会议>Conference on Computer-Aided Diagnosis >IDH Mutation Assessment of Glioma Using Texture Features of Multimodal MR Images
【24h】

IDH Mutation Assessment of Glioma Using Texture Features of Multimodal MR Images

机译:使用多模式MR图像的纹理特征IDH突变评估胶质瘤

获取原文

摘要

Purpose: To 1) find effective texture features from multimodal MRI that can distinguish IDH mutant and wild status, and 2) propose a radiomic strategy for preoperatively detecting IDH mutation patients with glioma. Materials and Methods: 152 patients with glioma were retrospectively included from the Cancer Genome Atlas. Corresponding Tl-weighted image before- and post-contrast, T2-weighted image and fluid-attenuation inversion recovery image from the Cancer Imaging Archive were analyzed. Specific statistical tests were applied to analyze the different kind of baseline information of LrGG patients. Finally, 168 texture features were derived from multimodal MRI per patient. Then the support vector machine-based recursive feature elimination (SVM-RFE) and classification strategy was adopted to find the optimal feature subset and build the identification models for detecting the IDH mutation. Results: Among 152 patients, 92 and 60 were confirmed to be IDH-wild and mutant, respectively. Statistical analysis showed that the patients without IDH mutation was significant older than patients with IDH mutation (p<0.01), and the distribution of some histological subtypes was significant different between IDH wild and mutant groups (p<0.01). After SVM-RFE, 15 optimal features were determined for IDH mutation detection. The accuracy, sensitivity, specificity, and AUC after SVM-RFE and parameter optimization were 82.2%, 85.0%, 78.3%, and 0.841, respectively. Conclusion: This study presented a radiomic strategy for noninvasively discriminating IDH mutation of patients with glioma. It effectively incorporated kinds of texture features from multimodal MRI, and SVM-based classification strategy. Results suggested that features selected from SVM-RFE were more potential to identifying IDH mutation. The proposed radiomics strategy could facilitate the clinical decision making in patients with glioma.
机译:目的:至1)找到可以区分IDH突变体和野生地位的多模式MRI的有效纹理特征,2)提出了一种术前检测胶质瘤术术患者的射辐射态策略。材料和方法:152例胶质瘤患者从癌症基因组地图集中批评。分析了与癌症成像档案中的对比度和后对比度,T2加权图像和流体衰减反演恢复图像进行的相应的TL加权图像。采用具体的统计测试来分析LRGG患者的不同类型基线信息。最后,来自每位患者的多模式MRI衍生168个纹理特征。然后采用了支持向量机基机的递归特征消除(SVM-RFE)和分类策略来查找最佳特征子集并构建用于检测IDH突变的识别模型。结果:152例患者中,92和60分别被证实为idH-野生突变体。统计分析表明,没有IDH突变的患者比IDH突变的患者显着(P <0.01),并且某些组织学亚型的分布在IDH野生和突变组之间存在显着差异(P <0.01)。在SVM-RFE之后,确定了15个最佳特征对于IDH突变检测。 SVM-RFE和参数优化后的准确性,敏感性,特异性和AUC分别为82.2%,85.0%,78.3%和0.841。结论:本研究介绍了胶质瘤患者的非侵袭性IDH突变的射域策略。它有效地掺入了来自多模式MRI的种类纹理特征和基于SVM的分类策略。结果表明,从SVM-RFE中选择的特征更具可能识别IDH突变。所提出的辐射族战略可以促进胶质瘤患者的临床决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号